93
Views
10
CrossRef citations to date
0
Altmetric
Articles

A Longitudinal Study of Syringe Acquisition by Puerto Rican Injection Drug Users in New York and Puerto Rico: Implications for Syringe Exchange and Distribution Programs

, , , , , , & show all
Pages 1313-1336 | Published online: 03 Jul 2009

References

  • Archibald C. P., Ofner M., Strathdee S. A., et al. Factors associated with frequent needle exchange program attendance in injectin drug users in Vancouver, Canada. J. Acquir. Immune Defric. Syndr. Hum. Retrovirol. 1998; 17(2)160–166
  • Bruneau J., Lamothe F., Franco E., et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am. J. Epidemiol. 1997; 146: 994–1002
  • Coffin P. Syringe availability as HIV prevention: a review of modalities. J. of Urban Health 2000; 77: 306–310
  • Colón H. M., Finlinson H. A., Robles R. R., et al. Joint drug purchases and drug preparation risk behaviors among injection drug users. AIDS and Behavior 2001; 5(1)85–96
  • Colón H. M., Finlinson H. A., Robles R. R., Deren S., Andia J. F., Kang S.-Y. 2003, Psychosocial and contextual covariates of drug preparation practices among injection drug users in Puerto Rico and New York City. Manuscript.
  • Deren S., Oliver-Vélez D., Finlinson H. A., Robles R. R., Andia J. F., Colón H. M. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Substance Use and Misuse 2003; 38(1)1–34
  • Deren S., Robles R. R., Andia J. F., Colón H. M.. HIV-related risk behaviors among Puerto Rican drug injectors in Puerto Rico and New York. Presented at the annual meeting of the American Public Health Association, Chicago, IL, 1999, November
  • Des Jarlais D. C. Research, politics, and needle exchange. Am. J. of Public Health 2000; 90(9)1392–1394
  • Dowling G. S., Johnson M. E., Fisher D. G., Needle R. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994; 1: 383–392
  • Finlinson H. A., Oliver-Vélez D., Colón H. M., et al. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: comparisons based on quantitative and qualitative methods. AIDS and Behavior 2000; 4(4)341–351
  • Fuller C. M., Ahern J., Vadnai L., et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J. Am. Pharmaceutical Association 2002; 42(6 Suppl 2)S77–82
  • Gibson D. R., Brand R., Anderson K., Kahn J. G., Perales D., Guydish J. Two- to six-fold decreased odds of HIV risk behavior associated with use of syringe exchange. JAIDS 2002; 31: 237–242
  • Gibson D. R., Flynn N. M., Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001; 15: 1329–1341
  • Gleghorn A. A., Gee G., Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/exchange prescription laws. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18(suppl 1)S89–S93
  • Gund J. P., Heckathorn D. D., Broadhead R. S., Anthony D. L. In eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995; 10: 82–89
  • Hagan H., Des Jarlais D. C., Purchase D., et al. An interview study of participants in the Tacoma, Washington syringe exchange. Addiction 1993; 88: 1691–1697
  • Hartgers C., van Ameijden E. J. C., van den Hoek J. A. R., Coutinho R. A. Needle sharing and participation in the Amsterdam syringe exchange program among HIV-seronegative injecting drug users. Public Health Rep. 1992; 107: 675–681
  • Heimer R., Khoshnood K., Bigg D. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(suppl 1)S37–S44
  • Hernandez R. New law eases sale of needles in an effort to curb AIDS. New York Times, , et al, May 6, 2000
  • Hurley S. F., Jolley D. J., Kaldorf J. M. Effectiveness of needle exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797–1800
  • Klein S. J., Harris-Valente K., Candelas A. R., et al. What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey. J of Urban Health 2001; 78(4)679–689
  • Lurie P., Reingold A. L., Bowser B., et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. University of California, Institute for Health Policy Studies, San Francisco, CA 1993
  • Lurie P. Invited commentary: le mystere de Montreal. Am. J. Epidemiol. 1997; 146: 1003–1006
  • MacDonald M., Wodak A. D., Ali R., et al. HIV prevalence and risk behavior in needle exchange attenders: a national study. Med. J. Aust. 1997; 166: 237–240
  • Mehta C., Patel N. StatXact 3 for Windows. CYTEL Software Corporation. , et al, Cambridge, MA 1995
  • Miller C. L., Tyndall M., Spittal P., Li K., Palepu A., Schechter M. T. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites and mobile van needle exchanges. J. Urban Health 2002; 79(2)257–265
  • Normand J., Vlahov D., Moses L. E. eds. Preventing HIV. Transmission: The Role of Sterile Needles and Bleach, , et al. National Academy of Medicine, Washington, DC 1995
  • Obadia Y., Feroini I., Perrin V., Vlahov D., Moatti J. P. Syringe vending machines for injection drug users: an experiment in Marseille, France. Am. J. Public Health 1999; 89: 1852–1854
  • Oliver-Vélez D., Finlinson H. A., Deren S., et al. Mapping the air-bridge locations: the application of ethnographic mapping techniques to a study of HIV risk behavior determinants in East Harlem, New York, and Bayamón, Puerto Rico. Human Organization 2002; 61(3)262–276
  • Paone D., Clark J., Shi Q., Purchase D., Des Jarlais D. C. Syringe exchange in the United States, 1996: a national profile. Am. J. Public Health 1999; 89: 43–46
  • Rich J. D., Macalino G. E., McKenzie M., Taylor L. E., Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am. J. Public Health 2001; 91(5)699–700
  • Riley E. D., Safaeian M., Strathdee S. A., et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. JAIDS 2000; 24: 57–61
  • Ruiz-Sierra J.. Research Brief: Syringe Access. The Lindesmith Center, Drug Policy Foundation, Sacramento, CA, 2001
  • Singer M., Baer H. A., Scott G., Horowitz S., Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Reports 1998; 113(Suppl 1)S81–S89
  • Strike C. J., Myers T., Millson M. Needle exchange: how the meanings ascribed to needles impact exchange practices and policies. AIDS Educ. Prev. 2002; 14(2)126–137
  • Statistical Package for the Social Sciences for Windows. SPSS, Inc., Chicago, IL 2002, (Version 11.5), [Computer software].
  • Stimson G. V. Syringe exchange programmes for injecting drug users. AIDS 1989; 3: 253–260
  • Strathdee S. A., Patrick D. M., Durrie S. L., et al. Needle exchange is not enough: lesions from the Vancouver injecting drug use study. AIDS 1997; 11: F59–F65
  • The New York Academy of Medicine. January 15, 2003, New York State Expanded Syringe Access Demonstration Program (ESAP): Evaluation Report to the Governor and State Legislature.
  • Valleroy L. A., Weinstein B., Jones T. S., Groseclose S. L., Rolfs R. T., Kassler W. J. Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995; 10(1)73–81
  • Van Ameijden E. J., van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 1992; 136: 236–243
  • Vlahov D., Junge B. The role of needle exchange programs in HIV prevention. Public Health Reports 1998; 113(S1)75–80
  • Weatherby N. L., Needle R., Cesari H., et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluations and Program Planning 1994; 17: 347–355
  • Weinstein B., Wright-De Aguero. AIDS prevention: attitudes of pharmacists toward OTC sale of sterile syringes. Drug Benefit Trends 1998; 10(8)1–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.